Literature DB >> 34614170

Education and Cardiovascular Health as Effect Modifiers of APOE ε4 on Dementia: The Atherosclerosis Risk in Communities Study.

Mark Lee1, Timothy M Hughes2,3, Kristen M George4, Michael E Griswold5, Sanaz Sedaghat6, Jeannette Simino7,8, Pamela L Lutsey6.   

Abstract

BACKGROUND: Both education and cardiovascular risk factors are strongly associated with dementia risk. However, it is not clear whether these associations persist or vary among individuals with high genetic risk for Alzheimer's disease. We examined the interactive relationship between lifestyle and genetic dementia risk factors in a prospective cohort study.
METHODS: Our data came from the Atherosclerosis Risk in Communities study participants (n = 13 715; baseline age 45-64; 25% Black; 55% female), who were followed for incident dementia from 1987 through 2017. We used Cox proportional hazard models to estimate the risk of dementia (ascertained through in-person examination, telephone cognitive screeners, and/or hospital and death records) associated with baseline education and cardiovascular risk factors (measured using the American Heart Association's "Life Simple 7") among ε4 carriers and non-carriers separately. We also examined differences by race and sex.
RESULTS: Two thousand two hundred and twenty-six incident dementia cases occurred over a median 25 years of follow-up. Lower educational attainment and poorer cardiovascular health were associated with greater risk of incident dementia. There was an education by apolipoprotein E (APOE) status interaction (p = .005) whereby the association of education and dementia was weaker for ε4 carriers (HR college graduates vs less than high school: 0.71 [0.59-0.84] than non-carriers (0.54 [0.47-0.63]). There was no interaction between APOE status and cardiovascular health on dementia risk. These relationships did not vary significantly by race or sex.
CONCLUSIONS: Education and cardiovascular health were associated with lower dementia risk regardless of APOE genotype, though the protective effects of education were somewhat diminished among ε4 carriers.
© The Author(s) 2021. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Cognitive aging; Gene by environment; Life Simple 7

Mesh:

Substances:

Year:  2022        PMID: 34614170      PMCID: PMC9159668          DOI: 10.1093/gerona/glab299

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.591


  38 in total

1.  Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence.

Authors:  Aaron R Folsom; Hiroshi Yatsuya; Jennifer A Nettleton; Pamela L Lutsey; Mary Cushman; Wayne D Rosamond
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

2.  Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.

Authors:  Scott C Neu; Judy Pa; Walter Kukull; Duane Beekly; Amanda Kuzma; Prabhakaran Gangadharan; Li-San Wang; Klaus Romero; Stephen P Arneric; Alberto Redolfi; Daniele Orlandi; Giovanni B Frisoni; Rhoda Au; Sherral Devine; Sanford Auerbach; Ana Espinosa; Mercè Boada; Agustín Ruiz; Sterling C Johnson; Rebecca Koscik; Jiun-Jie Wang; Wen-Chuin Hsu; Yao-Liang Chen; Arthur W Toga
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

3.  Interaction of Apolipoprotein E Genotypes, Lifestyle Factors and Future Risk of Dementia-Related Mortality: The Cohort of Norway (CONOR).

Authors:  Bjørn Heine Strand; Tor Atle Rosness; Knut Engedal; Per Magnus; Astrid Liv Mina Bergem; Henrik Schirmer; Espen Bjertness; Gun Peggy Knudsen
Journal:  Dement Geriatr Cogn Disord       Date:  2015-06-12       Impact factor: 2.959

Review 4.  Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription.

Authors:  Simon M Laws; Eugene Hone; Sam Gandy; Ralph N Martins
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

5.  Cardiovascular health, genetic risk, and risk of dementia in the Framingham Heart Study.

Authors:  Gina M Peloso; Alexa S Beiser; Claudia L Satizabal; Vanessa Xanthakis; Ramachandran S Vasan; Matthew P Pase; Anita L Destefano; Sudha Seshadri
Journal:  Neurology       Date:  2020-07-20       Impact factor: 9.910

6.  Is the gene-environment interaction paradigm relevant to genome-wide studies? The case of education and body mass index.

Authors:  Jason D Boardman; Benjamin W Domingue; Casey L Blalock; Brett C Haberstick; Kathleen Mullan Harris; Matthew B McQueen
Journal:  Demography       Date:  2014-02

7.  Education and APOE-e4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.

Authors:  Teresa E Seeman; Mei-Hua Huang; Philip Bretsky; Eileen Crimmins; Lenore Launer; Jack M Guralnik
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2005-03       Impact factor: 4.077

8.  Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  A Alonso; T H Mosley; R F Gottesman; D Catellier; A R Sharrett; J Coresh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-08-19       Impact factor: 10.154

9.  Education and dementia: what lies behind the association?

Authors:  T Ngandu; E von Strauss; E-L Helkala; B Winblad; A Nissinen; J Tuomilehto; H Soininen; M Kivipelto
Journal:  Neurology       Date:  2007-10-02       Impact factor: 9.910

Review 10.  Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.

Authors:  Angel Cedazo-Mínguez
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

View more
  1 in total

Review 1.  Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics.

Authors:  Lucia Migliore; Fabio Coppedè
Journal:  Nat Rev Neurol       Date:  2022-09-30       Impact factor: 44.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.